FDA Warns Two Breast Implant Makers Over Post-Approval Studies

The GMP Letter
A A
Two breast implant manufacturers were served with warning letters after the FDA found they failed to comply with post-approval study requirements.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00